Gaurav Shah

Mimecast Microsoft Office 365 iCIMS Remote

biotechnology company rare diseases therapeutics development gene therapy rare disease ladi fanconi anemia pkd danon disease clinical studies biotechnology: pharmaceutical preparations health care rare diseases clinical trials genetic testing patient advocacy heart disease safety & efficacy natural history studies expanded access policy leukocyte adhesion deficiency-i pyruvate kinase deficiency arrhythmogenic cardiomyopathy lamp2 protein expression lv mass reduction rare disease resources educational resources fda ema orphan drug designation regulatory affairs quality of life biotech industry innovative science patient-centric care advocacy organizations genetic disorders translational science multi-platform approach pharmaceutical research healthcare innovations personalized treatment collaborative research health authorities pivotal clinical trials research & development patient community support diversity in healthcare clinical development healthcare policy advocacy scientific collaborations biostatistics manufacturing processes safety monitoring comprehensive healthcare solutions healthcare management patient empowerment rare genetic diseases ex vivo lentiviral technology in vivo adeno-associated viral technology bone marrow disorders cardiovascular disorders leukocyte adhesion deficiency plakophilin-2 arrhythmogenic cardiomyopathy bag3 dilated cardiomyopathy patient-centric approach transformative therapies high unmet medical needs regulatory pathways strategic partnerships healthcare providers patient communities genetic correction curative potential manufacturing healthcare innovation patient support diversity & inclusion financial stability mission-driven trust curiosity generosity elevation health wellness & fitness hospital & health care mechanical or industrial engineering